Open-label, Phase I/IIa Study of VAC-3S in HIV-1 Patients Who Showed an Immune Response to VAC-3S During IVVAC-3S/P1
NCT02390466
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV
Interventions
BIOLOGICAL:
VAC-3S
Sponsor
InnaVirVax